Human Trials of SARS Vaccine Are Approved
From Times Wire Reports
China has approved human trials of an experimental SARS vaccine, and 30 people have already volunteered to be test subjects, state media reported.
Researchers cautioned that the trials would not mean the vaccine could be produced for widespread use any time soon, China Central Television said.
China has said the vaccine is made from a dead virus linked to severe acute respiratory syndrome. It said the vaccine was effective in animal tests.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
